DCF — RIVERSIDE UNIVERSITY HEALTH SYSTEM
Enterprise Value: $-1.5B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.5B
Enterprise Value
$-470.7M
PV of Cash Flows
$-1.0B
PV of Terminal Value
$-1.6B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $944.9M | $-92.3M | -10.0% | $-132.3M | $-120.3M |
| Year 2 | $973.3M | $-85.4M | -9.0% | $-126.6M | $-104.6M |
| Year 3 | $1.0B | $-77.9M | -8.0% | $-120.3M | $-90.4M |
| Year 4 | $1.0B | $-75.1M | -7.0% | $-118.8M | $-81.1M |
| Year 5 | $1.1B | $-74.7M | -7.0% | $-119.7M | $-74.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.5B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$917.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.102704772004101
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5